Serum Institue of India’s Poonawalla expects Omicron-specific vaccine in 6 months: Report

SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield.

• By: Reuters
• August 15, 2022 11:14 PM IST
1 min read

Serum Institute of India's Chief Executive Officer Adar Poonawalla (File Photo)

Serum Institute of India’s (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday.

SII, the world’s biggest vaccine maker, produces AstraZeneca’s COVID-19 vaccine under the brand name Covishield.

You have exhausted your
monthly limit of free stories.

Read more stories for free
with an Express account.

Register

Already have an account? Sign In

Read this and every other premium story with a digital subscription.

Buy now

Already a subscriber? Sign In

This premium article is free for now.

Register to continue reading this story

Free Read

Already have an account? Sign In

Read this and every other premium story with a digital subscription.

Buy now

This content is exclusive for our subscribers.

Subscribe now to get unlimited access to The Indian Express exclusive and premium stories.

Continue

Already a subscriber? Sign In

SII did not immediately respond to a Reuters request for comment.

From the homepage

Drama in Leh: Right before he could address press conference, Sonam Wangchuk detained

Amid walkouts, Netanyahu says Israel ‘must finish job in Gaza’, asks Hamas to surrender in UN speech

Bareilly protest over ‘I Love Mohammad’ banner turns violent: Stones pelted, vehicles damaged